First-line monotherapy with nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and correlation of outcomes with PD-L1 status Meeting Abstract
| Authors: | Rizvi, N. A.; Shepherd, F. A.; Antonia, S. J.; Brahmer, J. R.; Chow, L. Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N. E.; Gerber, D. E.; Shen, Y.; Harbison, C.; Chen, A. C.; Gettinger, S. |
| Abstract Title: | First-line monotherapy with nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and correlation of outcomes with PD-L1 status |
| Meeting Title: | 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 90 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2014 Oct 30-Nov 1 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-11-15 |
| Start Page: | S31 |
| Language: | English |
| ACCESSION: | WOS:000346413500067 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2014.08.204 |
| Notes: | Meeting Abstract: 165 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos |
